[Sudeck syndrome--a combined clinico-roentgenologic-nuclear medicine study].
147 patients with clinical suspicion of a Sudeck syndrome were submitted to X-ray and nuclear medical examinations. The clinical suspicion was confirmed in 122 patients. In six cases showing no X-ray symptoms, the diagnosis could only be confirmed by scintigraphy. A new classification of stages was necessary for therapeutic reasons: I = early stage, II = acute/subacute stage, III = healing stage, IV = defective recovery. Modifications due to therapy were demonstrated early by 100 scintigraphic check-up examinations, whereas the evidence of such modifications in X-ray pictures was delayed. The study describes the X-ray morphology as well as the scintigraphic manifestations of the Sudeck syndrome. The study shows that scintigraphy is a valuable examination method. It is useful in diagnosing early stages often not detected in X-ray examination, in the assessment of the evolution of a disease, and in the classification of stages.
Schurawitzki
H
H
Zentrales Institut für Radiodiagnostik, Universität Wien.
Wickenhauser
J
J
Fezoulidis
I
I
Sadil
V
V
Fialka
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D001842:Bone and Bones / Q000000981:diagnostic imaging; D004164:Diphosphonates; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011379:Prognosis; D011859:Radiography; D011877:Radionuclide Imaging; D012019:Reflex Sympathetic Dystrophy / Q000145:classification / Q000000981:diagnostic imaging*; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives
D004164:Diphosphonates; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C033905:technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D013669:Technetium Tc 99m Medronate
Das Sudeck-Syndrom--eine kombinierte klinisch-röntgenologisch-nuklearmedizinische Studie.